The OCMX™ is pleased to announce the listing of Wellesley Pharmaceuticals to its online portal which offers Investors and Advisors the ability to participate in this opportunity.

NEWTOWN, PA, March 28, 2018 /24-7PressRelease/ — Wellesley Pharmaceuticals, LLC was founded to ensure that the ability of Nocturol™ to reduce and sometimes eliminate nocturia symptoms can be disseminated to help the hundreds of millions of people who can benefit from it. Nocturol is a drug to treat nocturia, the frequent need to urinate at night. This sometimes-deadly condition afflicts 2.4 billion people and causes insomnia, fatigue, depression, lower quality of life, higher rates of heart disease, stroke, long term brain damage, and deadly falls.

The OCMX™ is pleased to announce the listing of Wellesley Pharmaceuticals to its online portal which offers Investors and Advisors the ability to participate in this opportunity.

The OCMX™ has spent considerable time completing its due diligence on Wellesley Pharmaceuticals and concluded that there is indeed a tremendous opportunity for Investors and Advisors.

The OCMX™ noted that Wellesley Pharmaceuticals exhibits the main components of any solid investment opportunity, namely a solid management team, a great track record, and a number of key competitive advantages.


David A. Dill, CEO and President | David Dill is the inventor of Nocturol and the founder of Wellesley Pharmaceuticals, LLC. Nine years ago he made six changes in his life and since then has over 100 inventions. When he realized that one of them could have a major impact on the world, he left his CFO position to focus fulltime on nocturia, which killed his father-in-law and leads to thousands of deaths per day. He graduated summa cum laude from Princeton University in 1973 with a degree in economics. He graduated from MIT’s Sloan School of Management in 1975 with a Master’s degree in finance and marketing. He spent 19 years at IBM rising to CFO of a $2 billion business unit. Since then he was VP Finance at General Instrument and CFO at 7 venture backed companies in 7 different industries, including Worldgate Communications, PlasticsNet, StorageApps, Digital 5, Telewares, Orchestria, and Undertone. Key Career Milestones Achieved: One IPO (Worldgate Communications in 1999), one sale of a company for $350 million (StorageApps sold to HP in 2001), over 100 inventions in the last 9 years.


The OCMX™ is literally changing how companies and investment funds generate exposure in the marketplace and raise funds as we know it. The OCMX™ serves both public and private companies along with investment and mutual funds which need to raise additional funds or gain significant market exposure. It does this by way of connecting the relevant companies, funds, investors, and advisors all in one online transparent portal. The OCMX™ (P2P Financial Inc.) launched in September of 2009 out of Toronto but has since expanded its operations to include Quebec, Alberta, Manitoba, and British Columbia.

The OCMX™ connects investors and advisors directly with companies and investment funds seeking to raise funds or gain broad market exposure. The OCMX™ provides an open venue for innovative growth companies and leading investment funds to generate market awareness, raise funds, or connect with investors and advisors. The OCMX™ provides companies, funds, investors, and advisors instant access to its Online Portal so that they can actively source and connect with their next opportunity, advisor, investor, client, or financing partner.

Contact Us
TD Canada Trust Tower
161 Bay Street, 45th Floor
Toronto, Ontario, M5J 2S1
Tel: 1-866-209-6862
Email: [email protected]

For the original version of this press release, please visit here